NEW YORK (GenomeWeb) – BioGx announced today that UK-based firm Launch Diagnostics will distribute assay products from BioGx's European-based subsidiary in the UK and Ireland.
As part of the multi-year partnership, Launch Diagnostics will collaborate with the Netherlands subsidiary of Birmingham, Alabama-based BioGx to distribute its CE-IVD-marked product line for infectious diseases, in addition to laboratory-use-only products, Template Positive Controls, and ValidPaks to expedite customer validation studies.
John Twycross, managing director of Launch Diagnostics, noted in a statement that the quality, menu expansion, and simplicity of BioGx's lyophilized assays "offer an all-in-one solution to [Becton Dickinson] MAX customers so they can increase their infectious disease test repertoire and use their instruments more cost effectively."
According to Ken Gordon, BioGx's VP of sales and marketing, the partnership with Launch Diagnostics will improve local end-user support, in addition to faster delivery time and competitive pricing.
Earlier this week, BioGx announced that it has partnered with AxonLab to distribute its products in multiple European countries.